Delivery Order SPE2DB20D3303-SPE2DB25FY1V2

Award Date 10/22/24
Potential Completion Date 10/23/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,573.98 firm-fixed-price delivery order is for the supply of 4,564,327,912 tablets of 27 mg extended-release methylphenidate. The contract has an ultimate completion date of April 19, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as the primary vehicle for...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,414.34 firm-fixed-price contract is for the supply of 4,566,477,023 units of 36 mg Methylphenidate extended-release tablets. The contract has an ultimate completion date of November 19, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $1,084.02 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. This order is for the supply of 4,564,792,761 tablets of Methylphenidate ER 36 mg, a prescription medication. The contract has a firm fixed price and an ultimate completion date of June 4, 2024. Amerisourcebergen holds a significantly larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,937.88 firm fixed price delivery order is for the supply of 4,565,045,029 methylphenidate extended-release 36mg tablets. The contract has a completion date of July 2, 2024 and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides methylphenidate extended-release tablets for the Defense Logistics Agency (DLA). The $2,327.56 firm fixed-price delivery order has a completion date of January 25, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the primary vehicle for supplying a wide range of...
This federal contract award from the Defense Logistics Agency (DLA) is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of methylphenidate extended-release 27 mg tablets in 100 count bottles. The total ceiling value of the delivery order is $2,282.40, with a firm fixed price and an ultimate completion date of October 31, 2024. This contract is not designated as a set-aside and represents an open competition award....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,414.26 firm fixed-price delivery order is for the supply of 4,566,434,637 units of Methylphenidate ER 18 mg tablets. The contract has an ultimate completion date of November 15, 2024 and was awarded on November 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,070.13, is a Delivery Order under an Indefinite Delivery Contract (IDC) for the supply of a specific medication, Methylphenidate ER 27 mg tablets. The contract has a Firm Fixed Price pricing type and a completion date of December 10, 2024. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,502,453 units of methylphenidate ER 18 mg tablets in 100-count bottles. The $1,519.44 firm fixed-price Delivery Order (DO) has a completion date of November 21, 2024 and is not subject to any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,552.33 firm-fixed-price delivery order is for the supply of 4566428019 - Methylphenidate ER 36 mg tablets. The contract has an ultimate completion date of November 7, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB25FY1V2
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order worth $7,170.24 and covers the supply of 4,566,176,682 methylphenidate extended-release 27 mg tablets in lots of 100. The contract has a firm fixed price pricing type and an ultimate completion date of October 23, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 1/22/25, 12:49 AM